183 related articles for article (PubMed ID: 28128094)
1. Efficacy of ceftaroline versus vancomycin in an experimental foreign-body and systemic infection model caused by biofilm-producing methicillin-resistant Staphylococcus epidermidis.
Domínguez-Herrera J; López-Rojas R; Smani Y; Labrador-Herrera G; Pachón J
Int J Antimicrob Agents; 2016 Dec; 48(6):661-665. PubMed ID: 28128094
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of daptomycin versus vancomycin in an experimental model of foreign-body and systemic infection caused by biofilm producers and methicillin-resistant Staphylococcus epidermidis.
Domínguez-Herrera J; Docobo-Pérez F; López-Rojas R; Pichardo C; Ruiz-Valderas R; Lepe JA; Pachón J
Antimicrob Agents Chemother; 2012 Feb; 56(2):613-7. PubMed ID: 22123684
[TBL] [Abstract][Full Text] [Related]
3. Repurposing of the Tamoxifen Metabolites to Treat Methicillin-Resistant Staphylococcus epidermidis and Vancomycin-Resistant Enterococcus faecalis Infections.
Miró-Canturri A; Vila-Domínguez A; Caretero-Ledesma M; Ayerbe-Algaba R; Pachón J; Jiménez-Mejías ME; Smani Y
Microbiol Spectr; 2021 Oct; 9(2):e0040321. PubMed ID: 34668743
[TBL] [Abstract][Full Text] [Related]
4. Activity of Tedizolid in Methicillin-Resistant Staphylococcus epidermidis Experimental Foreign Body-Associated Osteomyelitis.
Park KH; Greenwood-Quaintance KE; Schuetz AN; Mandrekar JN; Patel R
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855069
[TBL] [Abstract][Full Text] [Related]
5. Use of ceftaroline after glycopeptide failure to eradicate meticillin-resistant Staphylococcus aureus bacteraemia with elevated vancomycin minimum inhibitory concentrations.
Paladino JA; Jacobs DM; Shields RK; Taylor J; Bader J; Adelman MH; Wilton GJ; Crane JK; Schentag JJ
Int J Antimicrob Agents; 2014 Dec; 44(6):557-63. PubMed ID: 25282169
[TBL] [Abstract][Full Text] [Related]
6. In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model.
Jacqueline C; Caillon J; Le Mabecque V; Miègeville AF; Hamel A; Bugnon D; Ge JY; Potel G
Antimicrob Agents Chemother; 2007 Sep; 51(9):3397-400. PubMed ID: 17591849
[TBL] [Abstract][Full Text] [Related]
7. Activity of Different Antistaphylococcal Therapies, Alone or Combined, in a Rat Model of Methicillin-Resistant Staphylococcus epidermidis Osteitis without Implant.
Albac S; Labrousse D; Hayez D; Anzala N; Bonnot D; Chavanet P; Aslangul E; Croisier D
Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31740562
[TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamics of moxifloxacin versus vancomycin against biofilms of methicillin-resistant Staphylococcus aureus and epidermidis in an in vitro model.
Salem AH; Elkhatib WF; Ahmed GF; Noreddin AM
J Chemother; 2010 Aug; 22(4):238-42. PubMed ID: 20685626
[TBL] [Abstract][Full Text] [Related]
9. Could ceftaroline be an alternative therapy for linezolid resistant Staphylococcus epidermidis infections in Intensive Care Medicine?
Candel FJ; Baos E; Nieto M; Picazo JJ
Rev Esp Quimioter; 2015 Aug; 28(4):214-6. PubMed ID: 26200031
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid drain infection caused by pandrug-resistant Staphylococcus epidermidis successfully treated with ceftaroline in combination with fosfomycin and vancomycin.
Magrini E; Rando E; Del Giacomo P; Matteini E; Leanza GM; Sanmartin F; Carbone A; Maiuro G; Dusina A; Cingolani A
Diagn Microbiol Infect Dis; 2024 May; 109(1):116205. PubMed ID: 38422663
[TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy of tigecycline VERSUS vancomycin in an experimental model of soft tissue infection by methicillin-resistant Staphylococcus aureus producing Panton-Valentine leukocidin.
Antonopoulou A; Tsaganos T; Tzepi IM; Giamarellou H; Giamarellos-Bourboulis EJ
J Chemother; 2015 Feb; 27(2):80-6. PubMed ID: 24548093
[TBL] [Abstract][Full Text] [Related]
12. Integrated safety summary of CANVAS 1 and 2 trials: Phase III, randomized, double-blind studies evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.
Corrado ML
J Antimicrob Chemother; 2010 Nov; 65 Suppl 4():iv67-iv71. PubMed ID: 21115456
[TBL] [Abstract][Full Text] [Related]
13. The issue beyond resistance: Methicillin-resistant Staphylococcus epidermidis biofilm formation is induced by subinhibitory concentrations of cloxacillin, cefazolin, and clindamycin.
Mirzaei R; Yousefimashouf R; Arabestani MR; Sedighi I; Alikhani MY
PLoS One; 2022; 17(11):e0277287. PubMed ID: 36350834
[TBL] [Abstract][Full Text] [Related]
14. Ceftaroline-Fosamil efficacy against methicillin-resistant Staphylococcus aureus in a rabbit prosthetic joint infection model.
Gatin L; Saleh-Mghir A; Tasse J; Ghout I; Laurent F; Crémieux AC
Antimicrob Agents Chemother; 2014 Nov; 58(11):6496-500. PubMed ID: 25136014
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of ceftaroline and rifampin, alone or combined, in a rat model of methicillin-resistant
Albac S; Anzala N; Bonnot D; Mirfendereski H; Chavanet P; Croisier D
Microbiol Spectr; 2023 Dec; 11(6):e0015323. PubMed ID: 37791959
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of ceftaroline against staphylococci from prosthetic joint infection.
Park KH; Greenwood-Quaintance KE; Patel R
Diagn Microbiol Infect Dis; 2016 Feb; 84(2):141-3. PubMed ID: 26602948
[TBL] [Abstract][Full Text] [Related]
17. Ceftaroline fosamil: a cephalosporin with activity against methicillin-resistant Staphylococcus aureus.
Poon H; Chang MH; Fung HB
Clin Ther; 2012 Apr; 34(4):743-65. PubMed ID: 22444785
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of oritavancin in combination with rifampin or gentamicin against prosthetic joint infection-associated methicillin-resistant Staphylococcus epidermidis biofilms.
Yan Q; Karau MJ; Raval YS; Patel R
Int J Antimicrob Agents; 2018 Nov; 52(5):608-615. PubMed ID: 30048689
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Ceftaroline Alone and in Combination against Biofilm-Producing Methicillin-Resistant Staphylococcus aureus with Reduced Susceptibility to Daptomycin and Vancomycin in an In Vitro Pharmacokinetic/Pharmacodynamic Model.
Barber KE; Smith JR; Ireland CE; Boles BR; Rose WE; Rybak MJ
Antimicrob Agents Chemother; 2015 Aug; 59(8):4497-503. PubMed ID: 25987623
[TBL] [Abstract][Full Text] [Related]
20. Effects of Subinhibitory Concentrations of Ceftaroline on Methicillin-Resistant Staphylococcus aureus (MRSA) Biofilms.
Lázaro-Díez M; Remuzgo-Martínez S; Rodríguez-Mirones C; Acosta F; Icardo JM; Martínez-Martínez L; Ramos-Vivas J
PLoS One; 2016; 11(1):e0147569. PubMed ID: 26800524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
